CD4 and neoplasm: Depletion of T cells in vivo abrogated the delay in tumor progression observed following vaccination (Supplementary Figures S3A, B), suggesting that both CD4 and CD8 T cells contribute to antitumor immunity induced by neoantigen vaccination.